Evidence map›Paper›PMID 31053964›Full record

ReviewDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft2019

[Ophthalmology 2019-where do we stand? : An analysis of the treatment situation in Germany].

Alexander K Schuster, Christian Wolfram, Norbert Pfeiffer, Robert P Finger

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Minimally Invasive Glaucoma Surgery.Deutsches Arzteblatt international · 2025
    Pooled it
  2. Review
  3. Review
  4. Article
  5. [Importance of vision in old age].Zeitschrift fur Gerontologie und Geriatrie · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Real-world therapy and persistence of patients with neovascular age-related macular degeneration and diabetic retinopathy or diabetic macular edema: a German claims data analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  11. Article
  12. Article
  13. Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (Study of Health in Pomerania-TREND-1).Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  14. Article
  15. Duration of Consultations in an Outpatient Ophthalmology Unit.Deutsches Arzteblatt international · 2023
    Article
  16. Article
  17. Article
  18. Impact of the COVID-19 pandemic's first wave on the care and treatment situation of intravitreal injections in a German metropolitan region.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  19. Article
  20. [Glaucoma surgery today].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Alexander K SchusterAugenklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland. alexander.schuster@uni-mainz.de.
Christian WolframAugenklinik, Universitätsklinikum Eppendorf, Hamburg, Deutschland.
Norbert PfeifferAugenklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.
Robert P FingerUniversitäts-Augenklinik Bonn, Bonn, Deutschland.
Johannes Gutenberg University Mainz · DEKlinik und Poliklinik für Psychosomatische Medizin und Psychotherapie · DEUniversitäts-Augenklinik Bonn · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The needs-based provision of medical services to the population represents a challenge for ophthalmology, not least as eye diseases become more frequent with age. Age-related macular degeneration, glaucoma, diabetic retinopathy and cataract occur particularly often. So far only few current population-based data have been available in Germany; however, this is currently changing with several ongoing population-based cohort studies, such as the Gutenberg Health Study, the National Cohort and the Rhineland Study. Preliminary data from the Gutenberg Health Study show that the expected increase in the prevalence of eye diseases with ageing has occurred and the development is comparable with international data from industrial countries. Over the last 15 years age-related eye diseases have increased by 15-34% due to demographic changes. The number of ophthalmologists increased during this period by 19%; however, as an ever increasing proportion do not work full time, the treatment time in ophthalmology only increased by 1%. Particularly in the working relationship of private practice employees, more ophthalmologists are now working than 15 years ago, the majority in part-time employment, whereas the number of self-employed ophthalmologists has declined. For ophthalmological care planning it is important to consider not only the age-related increase in patients but also the changes in treatment capacity, which cannot be solely derived from the absolute number of actively involved ophthalmologists.

Indexed as

Diabetic RetinopathyGlaucomaMacular DegenerationOphthalmologyGermanyHumansEpidemiologyHealth services researchNeeds-based treatmentPrevalenceUtilization

Identifiers

PMID31053964
OpenAlexW2943359759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.